BrainChip

the Akida AKD1500 neuromorphic processor reached commercial availability and production shipments, with a Communication Reference Platform extending the architecture toward edge signal-intelligence applications.

Country: United States
Ticker: ASX:BRN

ASX: BRN Commercial

Coverage

	CN	EU	US
digital-it	✓	✓	✓

Regulatorsftcreach

Verifiable facts

Fact	Value	Source
Funding	$53M total raised over 4 rounds, with latest round of $22M on Dec 10, 2025 (2026-06-30)	kalkine.com.au · marketindex.com.au
Capacity	Approx. 60,000 units for initial production run (2026-06-30)	kalkine.com.au · marketindex.com.au
Certification	Undergoing industrial and military-grade qualification (2026-06-30) medium confidence	brainchip.com
Regulatory approval	None disclosed; currently undergoing environmental screening and qualification tests (2026-07-02)	business-news-today.com
Production site	Manufactured in partnership with GlobalFoundries (GF) using 22FDX technology (2026-06-30)	brainchip.com
Revenue	USD 1.22 million for the half-year ended June 30, 2026 (2026-06-30)	ca.marketscreener.com

Independent sources: business-news-today.com · ca.marketscreener.com · kalkine.com.au · marketindex.com.au

Technologies

Name	Cluster	Risk
Bio-inspired AI architectures	digital-it	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.